Agilent Technologies Debt to Equity Ratio 2010-2025 | A
Current and historical debt to equity ratio values for Agilent Technologies (A) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Agilent Technologies debt/equity for the three months ending January 31, 2025 was 0.56.
| Agilent Technologies Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-01-31 | $5.89B | $6.03B | 0.98 |
| 2024-10-31 | $5.95B | $5.90B | 1.01 |
| 2024-07-31 | $5.09B | $5.90B | 0.86 |
| 2024-04-30 | $4.64B | $6.21B | 0.75 |
| 2024-01-31 | $4.76B | $6.19B | 0.77 |
| 2023-10-31 | $4.92B | $5.85B | 0.84 |
| 2023-07-31 | $5.12B | $5.56B | 0.92 |
| 2023-04-30 | $5.01B | $5.78B | 0.87 |
| 2023-01-31 | $5.31B | $5.61B | 0.95 |
| 2022-10-31 | $5.23B | $5.31B | 0.99 |
| 2022-07-31 | $5.39B | $5.09B | 1.06 |
| 2022-04-30 | $5.33B | $5.12B | 1.04 |
| 2022-01-31 | $5.17B | $5.15B | 1.00 |
| 2021-10-31 | $5.32B | $5.39B | 0.99 |
| 2021-07-31 | $5.55B | $4.95B | 1.12 |
| 2021-04-30 | $5.59B | $4.81B | 1.16 |
| 2021-01-31 | $4.87B | $4.80B | 1.01 |
| 2020-10-31 | $4.75B | $4.87B | 0.98 |
| 2020-07-31 | $4.57B | $4.98B | 0.92 |
| 2020-04-30 | $4.69B | $4.77B | 0.98 |
| 2020-01-31 | $4.65B | $4.85B | 0.96 |
| 2019-10-31 | $4.70B | $4.75B | 0.99 |
| 2019-07-31 | $3.88B | $4.75B | 0.82 |
| 2019-04-30 | $3.90B | $5.13B | 0.76 |
| 2019-01-31 | $3.92B | $5.04B | 0.78 |
| 2018-10-31 | $3.97B | $4.57B | 0.87 |
| 2018-07-31 | $3.78B | $4.57B | 0.83 |
| 2018-04-30 | $4.17B | $4.62B | 0.90 |
| 2018-01-31 | $4.17B | $4.53B | 0.92 |
| 2017-10-31 | $3.59B | $4.84B | 0.74 |
| 2017-07-31 | $3.65B | $4.61B | 0.79 |
| 2017-04-30 | $3.64B | $4.38B | 0.83 |
| 2017-01-31 | $3.57B | $4.30B | 0.83 |
| 2016-10-31 | $3.55B | $4.25B | 0.84 |
| 2016-07-31 | $3.39B | $4.35B | 0.78 |
| 2016-04-30 | $3.48B | $4.17B | 0.83 |
| 2016-01-31 | $3.25B | $4.05B | 0.80 |
| 2015-10-31 | $3.31B | $4.17B | 0.79 |
| 2015-07-31 | $3.15B | $4.11B | 0.77 |
| 2015-04-30 | $3.25B | $4.16B | 0.78 |
| 2015-01-31 | $3.28B | $4.24B | 0.77 |
| 2014-10-31 | $5.51B | $5.30B | 1.04 |
| 2014-07-31 | $4.74B | $5.64B | 0.84 |
| 2014-04-30 | $5.40B | $5.63B | 0.96 |
| 2014-01-31 | $5.19B | $5.45B | 0.95 |
| 2013-10-31 | $5.40B | $5.29B | 1.02 |
| 2013-07-31 | $5.49B | $4.79B | 1.15 |
| 2013-04-30 | $5.28B | $5.31B | 1.00 |
| 2013-01-31 | $5.30B | $5.35B | 0.99 |
| 2012-10-31 | $5.35B | $5.19B | 1.03 |
| 2012-07-31 | $4.88B | $4.87B | 1.00 |
| 2012-04-30 | $4.69B | $4.73B | 0.99 |
| 2012-01-31 | $4.60B | $4.50B | 1.02 |
| 2011-10-31 | $4.74B | $4.32B | 1.10 |
| 2011-07-31 | $4.55B | $4.20B | 1.08 |
| 2011-04-30 | $4.69B | $3.96B | 1.18 |
| 2011-01-31 | $4.71B | $3.34B | 1.41 |
| 2010-10-31 | $6.46B | $3.24B | 2.00 |
| 2010-07-31 | $6.29B | $2.81B | 2.24 |
| 2010-04-30 | $5.14B | $2.63B | 1.95 |
| 2010-01-31 | $4.98B | $2.60B | 1.92 |
| 2009-10-31 | $5.10B | $2.51B | 2.03 |
| 2009-07-31 | $4.08B | $2.49B | 1.64 |
| 2009-04-30 | $4.16B | $2.42B | 1.72 |
| 2009-01-31 | $4.59B | $2.57B | 1.79 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $32.046B | $6.510B |
| Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.007B | 27.90 |
| Boston Scientific (BSX) | United States | $155.135B | 38.84 |
| Stryker (SYK) | United States | $149.698B | 31.30 |
| EssilorLuxottica (ESLOY) | France | $129.877B | 0.00 |
| Medtronic (MDT) | Ireland | $110.440B | 16.12 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.984B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.101B | 27.36 |
| ResMed (RMD) | United States | $36.449B | 27.38 |
| GE HealthCare Technologies (GEHC) | United States | $33.384B | 15.85 |
| Terumo (TRUMY) | Japan | $27.153B | 35.27 |
| Koninklijke Philips (PHG) | Netherlands | $22.822B | 16.41 |
| Insulet (PODD) | United States | $22.662B | 88.96 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.138B | 12.29 |
| Baxter (BAX) | United States | $15.929B | 11.89 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.591B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.030B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.618B | 23.03 |
| Lantheus Holdings (LNTH) | United States | $5.520B | 13.92 |
| Prestige Consumer Healthcare (PBH) | United States | $4.305B | 19.23 |
| Perrigo (PRGO) | Ireland | $3.614B | 9.16 |
| Haemonetics (HAE) | United States | $3.485B | 15.18 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.459B | 25.51 |
| Envista Holdings (NVST) | United States | $3.066B | 25.48 |
| QuidelOrtho (QDEL) | United States | $2.234B | 15.36 |
| GN Store Nord (GNNDY) | Denmark | $2.150B | 17.81 |
| LeMaitre Vascular (LMAT) | United States | $1.882B | 42.07 |
| AtriCure (ATRC) | United States | $1.599B | 0.00 |
| Neogen (NEOG) | United States | $1.424B | 18.22 |
| AdaptHealth (AHCO) | United States | $1.220B | 12.38 |
| Kestra Medical Technologies (KMTS) | United States | $1.220B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.209B | 27.19 |
| BioLife Solutions (BLFS) | United States | $1.045B | 0.00 |
| InMode (INMD) | Israel | $1.023B | 9.37 |
| Phibro Animal Health (PAHC) | United States | $0.966B | 12.35 |
| Evolus (EOLS) | United States | $0.645B | 0.00 |
| CeriBell (CBLL) | United States | $0.636B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.586B | 0.00 |
| Owens & Minor (OMI) | United States | $0.548B | 4.54 |
| Valneva SE (VALN) | France | $0.516B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.499B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.443B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.437B | 0.00 |
| Surmodics (SRDX) | United States | $0.401B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.354B | 0.00 |
| SNDL (SNDL) | Canada | $0.336B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.325B | 11.95 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.279B | 49.60 |
| Sanara MedTech (SMTI) | United States | $0.274B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.271B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.268B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.266B | 22.47 |
| Cerus (CERS) | United States | $0.247B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.246B | 0.00 |
| ZimVie (ZIMV) | United States | $0.242B | 11.00 |
| Omeros (OMER) | United States | $0.230B | 0.00 |
| Biote (BTMD) | United States | $0.220B | 6.18 |
| Brainsway (BWAY) | Israel | $0.188B | 49.90 |
| High Tide (HITI) | Canada | $0.187B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.184B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.180B | 14.51 |
| Quanterix (QTRX) | United States | $0.175B | 0.00 |
| Organigram Global (OGI) | Canada | $0.166B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.165B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 16.72 |
| Jin Medical (ZJYL) | China | $0.129B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.128B | 0.00 |
| Exagen (XGN) | United States | $0.122B | 0.00 |
| MacroGenics (MGNX) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
| Fonar (FONR) | United States | $0.084B | 10.83 |
| Veru (VERU) | United States | $0.075B | 0.00 |
| Agape ATP (ATPC) | $0.075B | 0.00 | |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.067B | 0.00 |
| Zynex (ZYXI) | United States | $0.066B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.065B | 0.00 |
| United Health Products (UEEC) | United States | $0.064B | 0.00 |
| Apyx Medical (APYX) | United States | $0.056B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.052B | 0.00 |
| ImmuCell (ICCC) | United States | $0.048B | 0.00 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.00 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Safety Shot (SHOT) | United States | $0.031B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 30.57 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.019B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |